MyFinsight
Home
Blog
About
Contact
Download
Download image
Accounts receivable, net
$187,802K
Marketable securities
$180,222K
Cash and cash
equivalents
$128,448K
Inventories, net
$82,385K
Prepaid expenses and
other current assets
$65,325K
Total current assets
$644,182K
Intangible assets, net
$569,456K
Goodwill
$124,882K
Other assets
$63,796K
Deferred income tax
assets, net
$38,351K
Property and equipment,
net
$10,531K
Restricted cash
$1,450K
Total assets
$1,452,648K
Total liabilities and
stockholders' equity
$1,452,648K
Total stockholders'
equity
$1,061,714K
Total liabilities
$390,934K
Accumulated other
comprehensive loss, net of tax
-$44K
Additional paid-in capital
$543,825K
Retained earnings
$517,876K
Common stock, 0.001 par
value 130,000,000...
$57K
Total current
liabilities
$338,171K
Operating lease
liabilities, long-term
$30,365K
Other liabilities
$22,192K
Contingent consideration,
long-term
$206K
Accrued product returns
and rebates
$161,097K
Accounts payable and
accrued liabilities
$107,800K
Other current
liabilities
$38,222K
Contingent consideration,
current portion
$31,052K
Back
Back
Balance Sheet
source: myfinsight.com
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
SUPERNUS PHARMACEUTICALS, INC. (SUPN)